Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Breast Cancer
- Prostate Cancer
- Quality of Life
- Survivorship
- Toxicity
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Supportive Care
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04879563
- Collaborators
- UBITECH
- ATOS
- Siemens Corporation, Corporate Technology
- Intrasoft
- Arthur's Legal
- University of Patras
- FORTH - Foundation for Research and Technology Hellas
- Sphynx Technology Solutions AG
- Faculty of Sciences, University of Novi Sad, Serbia
- DFKI - German Research Center for Artificial Intelligence
- Fundacio Clinic Barcelona
- CareAcross
- National and Kapodistrian University of Athens, Greece
- Fundacion iSYS
- Investigators
- Study Director: Paris Kosmidis CareAcross Study Director: Serge Autexier German Research Center for Artificial Intelligence
Get Well Soon